MitoChroma Research

MitoChroma Research is a preclinical-stage biotechnology company dedicated to addressing mitochondrial dysfunction, a central driver of cellular aging and various degenerative diseases. Founded by Dr. Michael Fossel, a pioneer in longevity science, the company focuses on developing mitochondrial-targeted small molecules and chromophores designed to restore cellular energy production and mitigate oxidative damage. MitoChroma Research's therapeutic approach aims to stabilize mitochondrial function to extend healthy lifespan and provide novel treatments for neurodegenerative and metabolic conditions. The company operates as a specialized entity exploring the intersection of mitochondrial health and longevity, complementing telomere-based research with energetic and metabolic interventions.